Thank you for sharing!

Your article was successfully shared with the contacts you provided.

NEW YORK CITY-Cushman & Wakefield has been named to market and lease the new Alexandria Center for Science and Technology at the forthcoming East River Science Park. The project has been zoned for up to 1.1 million square feet of office and laboratory space, and is intended as the centerpiece of the city’s efforts to develop the life sciences market.

The first phase of development will consist of an East Tower totaling approximately 320,000 square feet, followed by a West Tower totaling approximately 420,000 square feet, according to Pasadena, CA-based Alexandria Real Estate Equities. The project is ultimately expected to create as many as 2,000 new jobs for bioscience professionals, according to a release. It will occupy 3.5 acres in Midtown South between East 28th and 29th streets and First Avenue and Franklin D. Roosevelt Drive.

C&W executive director William Hartman, who is leading the marketing and leasing team on the assignment, says in a release that the project “is certain to become one of North America’s most desired destinations for life science companies at all stages of development.” He adds that it will combine New York City’s “deep talent pool, global presence, unmatched 24/7 amenities and resources with Alexandria’s extensive life science experience and expertise in developing life science clusters.”

Last January, Real Estate New York reported that it was a proximity to the city’s wealth of medical institutions that helped to attract Alexandria, a developer long active in biotech clusters across the US. In addition, “The city and state’s willingness to try something out of the box to establish a biotech center was a major factor” in persuading Alexandria to submit a proposal, Joel S. Marcus, the REIT’s chairman and CEO, told RENY at the time. Lenzie Harcum, vice president for biosciences at the New York City Economic Development Corp, said in January that the Bloomberg administration made life sciences a priority.

To that end, the city is providing about $13.4 million in capital funds for the project, while the state will kick in $27 million to be used for infrastructure work in connection with the project. Scott Stringer, Manhattan borough president, is contributing $500,000. In addition, the New York City Investment Fund, will provide $10 million in funding to be used for ERSP tenant improvements. The project will also receive about $5.6 million through the New York City Industrial Development Agency, and about $2 million in additional federal funds have also been secured.

Marcus told RENY in January that the project’s first phase hopes to attract “small, medium and large” biotech companies along with manufacturers of MET, or microcurrent electrotherapy, devices. The site will also include a glass-enclosed pavilion between the two towers and contain underground parking facilities, a café, a conference center and ground-floor retail space.

Along with Hartman, the C&W team includes EVP Jonathan Serko, senior director Barry Zeller and director David Malawer, all from the Midtown office; C&W’s global life science practice consisting of Mark Winters, Christopher Kinum, Thomas Giannone and John Minervini; Marc Packman of the firm’s strategic agency services; and the global consulting group comprised of Matthew Jackson and Matthew Highfield.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 3 free articles* across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.